Revenue GrowthXtalPi leverages its proprietary AI-powered R&D platform to deliver stable and accelerating revenue growth across two core business areas: drug discovery and intelligent robotics.

Strategic PartnershipsXtalPi collaborates with leading global and domestic pharma companies, enhancing its strategic position in drug discovery.

Bears Say

R&D RisksRisks include potential delays in partnered R&D pipelines, uncertainty in commercialization sustainability, and possible sell-off following lock-up expiry.

QuantumPharm, Inc. News

XtalPi and DoveTree Enter Definitive Agreement for AI-Driven Drug Discovery

QuantumPharm, Inc. ( ($HK:2228) ) has shared an announcement. XtalPi Holdings Limited, through its subsidiary Shenzhen XtalPi Technology...

2d ago

2228

XtalPi Partners with DoveTree for AI-Driven Drug Discovery

An update from QuantumPharm, Inc. ( ($HK:2228) ) is now available. XtalPi Holdings Limited has entered into a...

2M ago

2228

XtalPi Co-Founders Extend Lock-Up, Signaling Confidence

QuantumPharm, Inc. ( ($HK:2228) ) just unveiled an update. XtalPi Holdings Limited, a company incorporated in the Cayman...

2M ago

2228

XtalPi Holdings Acquires 90% Stake in Target Company for RMB250 Million

The latest update is out from QuantumPharm, Inc. ( ($HK:2228) ). XtalPi Holdings Limited, a company incorporated in...

3M ago

2228

XtalPi Holdings AGM Resolutions Passed with Overwhelming Support

An announcement from QuantumPharm, Inc. ( ($HK:2228) ) is now available. XtalPi Holdings Limited, a company incorporated in...

3M ago

2228

XtalPi Holdings Limited Announces 2025 AGM and Key Resolutions

QuantumPharm, Inc. ( ($HK:2228) ) has provided an update. XtalPi Holdings Limited has announced its upcoming Annual General...

4M ago

2228

XtalPi Achieves Commercial Company Status on Hong Kong Stock Exchange

QuantumPharm, Inc. ( ($HK:2228) ) has shared an announcement. XtalPi Holdings Limited, a company incorporated in the Cayman...

4M ago

2228

QuantumPharm, Inc.: Strong Market Position and Growth Potential Driven by Robotics and Strategic Partnerships

CMB International Securities analyst Jill Wu maintained a Buy rating on QuantumPharm, Inc. (2228 – Research Report) yesterday...

4M ago

XtalPi Reports Revenue Growth and Operational Efficiency in 2024

QuantumPharm, Inc. ( ($HK:2228) ) just unveiled an announcement. XtalPi Holdings Limited announced its annual results for the...

4M ago

2228

XtalPi Holdings Partners with Chinese Ministry to Boost AI Integration in Industries

QuantumPharm, Inc. ( ($HK:2228) ) has issued an announcement. XtalPi Holdings Limited has announced a strategic cooperation agreement...

4M ago

2228

2228 FAQ

What was QuantumPharm, Inc.’s price range in the past 12 months?

QuantumPharm, Inc. lowest stock price was HK$3.05 and its highest was HK$16.20 in the past 12 months.

What is QuantumPharm, Inc.’s market cap?

QuantumPharm, Inc.’s market cap is HK$26.50B.

When is QuantumPharm, Inc.’s upcoming earnings report date?

QuantumPharm, Inc.’s upcoming earnings report date is Mar 28, 2025 which is 132 days ago.

How were QuantumPharm, Inc.’s earnings last quarter?

Currently, no data Available

Is QuantumPharm, Inc. overvalued?

According to Wall Street analysts QuantumPharm, Inc.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does QuantumPharm, Inc. pay dividends?

QuantumPharm, Inc. pays a Notavailable dividend of HK$0.007 which represents an annual dividend yield of N/A. See more information on QuantumPharm, Inc. dividends here

What is QuantumPharm, Inc.’s EPS estimate?

QuantumPharm, Inc.’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does QuantumPharm, Inc. have?

QuantumPharm, Inc. has 4,017,001,700 shares outstanding.

What happened to QuantumPharm, Inc.’s price movement after its last earnings report?

Currently, no data Available

Which hedge fund is a major shareholder of QuantumPharm, Inc.?

Currently, no hedge funds are holding shares in HK:2228

QuantumPharm, Inc. Stock Smart Score

Neutral

Fundamentals

Return on Equity

―

Trailing 12-Months

Asset Growth

5.08%

Trailing 12-Months

Top Smart Score Stocks >

Company Description

QuantumPharm, Inc.

XtalPi Holdings Limited, an investment holding company, provides drug discovery and intelligent automation solutions in China, the United States, Europe, South Korea, and Japan. The company's drug discovery solutions cover the whole drug discovery and research process, including target validation, hit identification, lead generation, lead optimization, and PCC nomination covering various modalities, which comprise small molecules, antibodies, peptides, ADC, and PROTAC. Its intelligent automation solutions focus on AI- and automation-enabled novel drug and materials discovery and research. The company was formerly known as QuantumPharm Inc. and changed its name to XtalPi Holdings Limited in December 2024. XtalPi Holdings Limited was founded in 2015 and is headquartered in Shenzhen, China.